Table 4 |
||||||
|
Estimates of P-value for the heterozygosity tests for each population of the A. moucheti group. |
||||||
|
Collection site |
TPM |
SMM |
||||
|
|
||||||
|
70%a |
80%a |
90%a |
||||
|
|
||||||
|
Cameroon |
Simbock |
He>Heq |
7 |
6 |
4 |
3 |
|
Sign test |
0.360 |
0.619 |
0.192 |
0.066 |
||
|
Wilcoxon test |
0.322 |
0.695 |
0.625 |
0.024* |
||
|
Olama |
He>Heq |
7 |
6 |
5 |
3 |
|
|
Sign test |
0.377 |
0.609 |
0.396 |
0.067 |
||
|
Wilcoxon test |
0.275 |
1 |
0.492 |
0.084 |
||
|
Nyabessan |
He>Heq |
8 |
8 |
6 |
4 |
|
|
Sign test |
0.158 |
0.149 |
0.608 |
0.184 |
||
|
Wilcoxon test |
0.010* |
0.016* |
0.625 |
0.432 |
||
|
Mouloundou |
He>Heq |
7 |
5 |
4 |
2 |
|
|
Sign test |
0.362 |
0.376 |
0.183 |
0.015* |
||
|
Wilcoxon test |
0.557 |
0.846 |
0.275 |
0.019* |
||
|
DRC |
Kenge |
He>Heq |
7 |
7 |
7 |
7 |
|
Sign test |
0.355 |
0.395 |
0.351 |
0.376 |
||
|
Wilcoxon test |
0.019* |
0.105 |
0.432 |
0.557 |
||
|
Tsakalakuku |
He>Heq |
4 |
4 |
4 |
3 |
|
|
Sign test |
0.212 |
0.212 |
0.225 |
0.575 |
||
|
Wilcoxon test |
0.625 |
0.625 |
0.625 |
1 |
||
|
Uganda |
Bufurima |
He>Heq |
2 |
2 |
1 |
1 |
|
Sign test |
0.015* |
0.015* |
0.002** |
0.002** |
||
|
Wilcoxon test |
0.032 |
0.010* |
0.003** |
0.002** |
||
|
|
||||||
|
TPM, two-phase mutation model with a % single step mutation; SMM, stepwise mutation model. He>Heq, number of loci with He>Heq (out of 10 loci tested in each sample, except the A. m. bervoetsi sample from Tsakalakuku where only 5 polymorphic loci were considered). * P < 0.05 and ** P < 0.01 (two tails P-values for deviation from MDE) after correction for multiple testing. |
||||||
|
Antonio-Nkondjio et al. Malaria Journal 2008 7:120 doi:10.1186/1475-2875-7-120 |
||||||
